

Other version: https://jamanetwork.com/journals/jama/fullarticle/2789039
![]() |
Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia |
|
Authors | ||
Published in | JAMA. 2022, vol. 327, no. 7, p. 682-683 | |
Abstract | Comment on: COVID STEROID 2 Trial Group, Munch MW, Myatra SN, Vijayaraghavan BKT, Saseedharan S, Benfield T, Wahlin RR, Rasmussen BS, Andreasen AS, Poulsen LM, Cioccari L, Khan MS, Kapadia F, Divatia JV, Brøchner AC, Bestle MH, Helleberg M, Michelsen J, Padmanaban A, Bose N, Møller A, Borawake K, Kristiansen KT, Shukla U, Chew MS, Dixit S, Ulrik CS, Amin PR, Chawla R, Wamberg CA, Shah MS, Darfelt IS, Jørgensen VL, Smitt M, Granholm A, Kjær MN, Møller MH, Meyhoff TS, Vesterlund GK, Hammond NE, Micallef S, Bassi A, John O, Jha A, Cronhjort M, Jakob SM, Gluud C, Lange T, Kadam V, Marcussen KV, Hollenberg J, Hedman A, Nielsen H, Schjørring OL, Jensen MQ, Leistner JW, Jonassen TB, Kristensen CM, Clapp EC, Hjortsø CJS, Jensen TS, Halstad LS, Bak ERB, Zaabalawi R, Metcalf-Clausen M, Abdi S, Hatley EV, Aksnes TS, Gleipner-Andersen E, Alarcón AF, Yamin G, Heymowski A, Berggren A, La Cour K, Weihe S, Pind AH, Engstrøm J, Jha V, Venkatesh B, Perner A. Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial. JAMA. 2021 Nov 9;326(18):1807-1817. doi: 10.1001/jama.2021.18295. Erratum in: JAMA. 2021 Dec 14;326(22):2333. Erratum in: JAMA. 2022 Jan 18;327(3):286. PMID: 34673895; PMCID: PMC8532039. | |
Keywords | Adult — COVID-19 / drug therapy — Dexamethasone / therapeutic use — Humans — Hypoxia / etiology — SARS-CoV-2 | |
Identifiers | PMID: 35166808 | |
Full text |
![]() ![]() Other version: https://jamanetwork.com/journals/jama/fullarticle/2789039 |
|
Structures | ||
Research group | VIH/SIDA (930) | |
Citation (ISO format) | ABOUIR, Kenza, CALMY, Alexandra, ING LORENZINI, Kuntheavy. Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia. In: JAMA, 2022, vol. 327, n° 7, p. 682-683. doi: 10.1001/jama.2021.24532 https://archive-ouverte.unige.ch/unige:161544 |